A natural history of melanoma: Serial gene expression analysis

Immunology Today

Volumn 21, Issue 12, 2000, Pages 619-623

  Wang, Ena ^a   Marincola, Francesco M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC POLYMORPHISM; HOST CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; MELANOMA; MOLECULAR INTERACTION; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY; TUMOR REJECTION;

EID: 0034509677     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01724-2     Document Type: Note

References (30)

1. Tumor antigens recognized by T cells
2. Cancer vaccines based on the identification of genes encoding cancer regression antigens
3. New paths in human cancer serology
4. Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma
5. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
6. Escape of human solid tumors from T cell recognition: Molecular mechanisms and functional significance
7. Activation or frustration of anti-tumor responses by T-cell-based immune modulation
8. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
9. Is cancer dangerous to the immune system?
10. Immune surveillance against a solid tumor fails because of immunological ignorance
11. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: Evidence for in vivo priming by tumor cells
12. Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response
13. Stringent allele/epitope requirements for MART-1/Melan A immunodominance: Implications for peptide-based immunotherapy
14. Heterogeneous expression of melanoma-associated antigens (MAA) and HLA-A2 in metastatic melanoma in vivo
15. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition
16. Identification of a tumor infiltrating lymphocyte recognizing MAGE-12 in a melanoma metastasis with decreased expression of melanoma differentiation antigens
17. Expansion of tumor/T cell pairs from fine needle aspirates (FNA) of melanoma metastases
18. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
19. Functional genomics: It's all how you read it
20. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
21. The new genomics: Global view of biology
22. Use of cDNA microarray to analyse gene expression patterns in human cancer
23. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
24. Molecular classification of cutaneous malignant melanoma by gene expression: Shifting from a continuous spectrum to distinct biologic entities
25. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
26. Cluster analysis and display of genome-wide expression patterns
27. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling and adhesion
28. Exploring the new world of the genome with DNA microarrays
29. Expression profiling using cDNA microarrays
30. High fidelity mRNA amplification for gene profiling using cDNA microarrays